TAK   $12.96  -2.11% Market Closed After Close 13.175 1.66%

Takeda Pharmaceutical Co Ltd
Total Cash 859.02B
totalCashPerShare 541.904
EBITDA 1.33T
Total Debt 5.61T
quickRatio 0.662
currentRatio 1.279
Total Revenue 4.55T
debtToEquity 81.042
Revenue/Share 1445.8774
ROA 0.02775
ROE 0.04147
grossProfits
freeCashflow 446.48B
operatingCashflow 876.31B
earningsGrowth
revenueGrowth 0.127
grossMargins 0.65946996
ebitdaMargins 0.29224002
operatingMargins 0.20538001
profitMargins 0.06379
enterpriseValue 4.77T
forwardPE 25.537037
floatShares 1.57B
sharesOutstanding 3.17B
sharesShort 7.30M
sharesShortPriorMonth 8.39M
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.02%
Short Ratio help_outline 3.71%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 4365.909
Price To Book help_outline 0.00
earningsQuarterlyGrowth
netIncomeToCommon 290.00B
trailingEps 0.60%
forwardEps 0.54%
enterpriseToEbitda 3.59
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.63 4Q 2024
institutionsCount 345
lastUpdated Nov. 7, 2024, 1:50 a.m.